Abstract: A method for measuring activation energy of a catalyst is disclosed, which includes obtaining a resonant frequency change-time curve using an integrated self-heating resonant cantilever (100), converting the resonant frequency change-time curve into a resonant frequency change-temperature curve, converting the resonant frequency change-temperature curve into a coverage-temperature curve, obtaining a coverage change rate-temperature curve by performing first-order differentiation on the coverage-temperature curve, obtaining relevant parameters corresponding to local minimum values from the coverage change rate-temperature curve, and substituting the relevant parameters into calculation formulas to obtain a desorption rate constant of the catalyst and a desorption activation energy of the catalyst. It can be seen that the present disclosure simply requires programmed heating in terms of operating on the samples, which is fast and convenient.

Abstract: Disclosed is an IL-15 mutant fusion protein preparation. Specifically, provided is an IL-15 mutant fusion protein pharmaceutical composition. The composition comprises an IL-15 mutant fusion protein, a buffer solution, a protein stabilizer and a surfactant. The pharmaceutical composition can maintain the stability of the IL-15 mutant fusion protein in the long-term storage and transportation process of the product, and thus, the stability, safety and effectiveness of the drug are ensured.

Abstract: A control device for adhesion and detachment is provided and includes a base, an actuator, and a movement mechanism including a bearing unit, a peeling unit, and an adhesion unit. The peeling unit is a thin sheet with a high elastic modulus and has a first side and a second side that are opposite to each other. An upper surface of the peeling unit is fixed on a lower surface of the bearing unit. The actuator is fixed to the first side of the peeling unit. The adhesion unit is arranged on a lower surface of the peeling unit. The peeling unit bends and elastically deforms from the first side towards the second side under an action of the actuator in such a manner that the adhesion unit moves synchronously. The peeling unit is in a flat state upon a recovery from the elastic deformation.

Abstract: Dentifrice compositions comprising water, bicarbonate salt, and glycine or a salt thereof are effective in treating dental plaque biofilm. A dentifrice composition may include from about 15% to about 55%, by weight of the composition, of water, from about 20% to about 40% by weight of the composition, of sodium bicarbonate, from about 0.05% to about 5%, by weight of the composition, of neutral amino acid, where the neutral amino acid comprises glycine or a salt thereof, and from about 0.0025% to about 2%, by weight of the composition, of fluoride.

Abstract: The embodiments of the present disclosure provide a cleaning device, the cleaning device including a body and a floor brush. The floor brush is connected to one end of the device body; the device body is provided with a sewage storage box, and the box body of the sewage storage box is at least for storing and/or filtering garbage suctioned by the floor brush. When the cleaning device is tilted or laid flat for use, no sewage may flow back into the motor from the sewage storage box, which prevents causing the motor to stop or be damaged, and ensures a normal use of the cleaning device.

Abstract: The present disclosure provides a cleaning device. The cleaning device may include a machine body, a cleaning liquid tank, and a floor brush, wherein the floor brush may be connected to an end of the machine body, the cleaning liquid tank may be arranged above the floor brush, and the cleaning liquid tank may be configured to provide cleaning liquid for the floor brush or floor. When a user uses the cleaning device for cleaning work, the user may hold the machine body to control a moving direction of the floor brush. In the cleaning device, by setting a cleaning liquid tank on the floor brush, a volume and weight of the machine body can be reduced, which reduces an overall volume and weight of the cleaning device, thereby reducing a load and weight when the user operates the machine body and improving experience of the user during cleaning work.

Abstract: The present invention provides a pharmaceutical composition for treating myocardial ischemia, comprising Salvia Miltiorrhiza medicinal material 250-700 parts by weight, Radix Notoginseng medicinal material 50-150 parts by weight, Borneolum Syntheticum 3-9 parts by weight, and ranolazine 25-100 parts by weight. According to a further aspect of the present invention, there is provided a use of a pharmaceutical composition for preparation of a medicine for prevention and/or treatment of myocardial ischemia.

Abstract: The disclosure relates to a non-national standard turnout drive system based on a double 2-vote-2 architecture, including an interlocking processing subsystem IPS, an interlocking maintenance station SDM, a non-national standard turnout drive module HIOM and an interlocking maintenance station SDM, wherein the non-national standard turnout drive module HIOM, a full-electronic communication module EIOCOM2, and the interlocking processing subsystem IPS are connected with each other in order, and the full-electronic communication module EIOCOM2 is connected to the interlocking maintenance station SDM; two non-national standard turnout drive module HIOMs, which are mutually redundant, obtain turnout drive commands through the interlocking processing subsystem IPS to control drive relays in a non-national standard turnout to lift and fall for driving the turnout to rotate toward a specified direction, while collecting representation information of the turnout and determining a position of the turnout.

Abstract: Dentifrice compositions comprising water, bicarbonate salt, and glycine or a salt thereof are effective in treating dental plaque biofilm.

Abstract: An antibody or antigen-binding fragment specifically binds to human programmed cell death ligand-1 (PD-L1). The antibody or antigen-binding fragment is able to enhance the function of T cells and upregulate a T cell-mediated immune response. The antibody or the antigen-binding fragment is useful for the treatment of diseases, e.g. tumor, associated with aberrant expression of PD-L1 and/or dysfunction of T cells.

Abstract: An electrical connector includes a main body portion having a receiving passage adapted to receive a plate-type plug inserted in an insertion direction, and a locking protrusion formed on the main body portion and protruding toward the receiving passage. The locking protrusion has a connection portion adapted to connect a top portion of the locking protrusion with the main body portion downstream in the insertion direction.

Abstract: Disclosed are a pharmaceutical composition and an application thereof. The pharmaceutical composition of the present invention comprises the following components in parts by weight: 2-20 parts of phenolic acids, 0.5-5 parts of flavonoids, 0.005-0.5 part of tanshinones, 5-20 parts of saponins, and 10-18 parts of volatile oils. The pharmaceutical composition has the functions of protecting against myocardial damage and treating heart failure.

Abstract: The present disclosure relates to laser machining equipment for grinding semiconductor wafers, and belongs to the field of laser machining equipment. The laser machining equipment mainly comprises a special fixture, laser measuring meters, a laser emission module, an X-axis movement system, a Y-axis movement system, a Z-axis movement system, a liftable laser machining workbench, data transmission cables, an industrial personal computer and a human-computer interface.

Abstract: An antibody or an antigen-binding fragment thereof capable of specifically binding to TNFR2, the antibody or the antigen-binding fragment thereof is capable of regulating the function of immune cells and may be used as a medicament to treat diseases related to immune-related disorders, such as tumors.

Abstract: An electrical connector includes a main body portion having a receiving passage adapted to receive a plate-type plug inserted in an insertion direction, and a locking protrusion formed on the main body portion and protruding toward the receiving passage. The locking protrusion has a connection portion adapted to connect a top portion of the locking protrusion with the main body portion downstream in the insertion direction.

Abstract: Disclosed is a control device for adhesion and detachment, including a base, an actuator, and a movement mechanism including a bearing unit, a peeling unit, and an adhesion unit. The peeling unit is a thin sheet with a high elastic modulus and has a first side and a second side that are opposite to each other. An upper surface of the peeling unit is fixed on a lower surface of the bearing unit. The actuator is fixed to the first side of the peeling unit. The adhesion unit is arranged on a lower surface of the peeling unit. The peeling unit bends and elastically deforms from the first side towards the second side under an action of the actuator in such a manner that the adhesion unit moves synchronously. The peeling unit is in a flat state upon a recovery from the elastic deformation.